Cre8 EVO Stents Noninferior for PCI in Diabetes Patients With CAD
Cre8 EVO stents noninferior to Resolute Onyx stents for target-lesion failure composite outcome at one year
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.